171 related articles for article (PubMed ID: 10722317)
1. Carvedilol--A new nonselective beta blocker.
Forrest E; Stanley A; Hayes P
Hepatology; 2000 Mar; 31(3):809-11. PubMed ID: 10722317
[No Abstract] [Full Text] [Related]
2. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
3. [Carvedilol in cardiac decompensation].
Dib J
Rev Med Liege; 1996 Feb; 51(2):198-200. PubMed ID: 8650455
[No Abstract] [Full Text] [Related]
4. Carvedilol and the kidney.
Dupont AG
Clin Investig; 1992; 70 Suppl 1():S127-31. PubMed ID: 1350479
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker therapy in heart failure: pathophysiology and clinical results.
Carson PE
Curr Probl Cardiol; 1999 Jul; 24(7):421-60. PubMed ID: 10403092
[No Abstract] [Full Text] [Related]
6. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis.
Sinagra E; Perricone G; D'Amico M; Tinè F; D'Amico G
Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic benefits and safety of carvedilol in the treatment of renal hypertension. An open, short term study. Carvedilol Renal Hypertension Study Group in Japan.
Kohno M; Takeda T; Ishii M; Saruta T; Mizuno Y; Yoshimura M; Kubo S; Fukiyama K; Fujishima M
Drugs; 1988; 36 Suppl 6():129-35. PubMed ID: 2908299
[TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
Hobolth L; Bendtsen F; Hansen EF; Møller S
Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome associated with carvedilol therapy.
Kowalski BJ; Cody RJ
Am J Cardiol; 1997 Sep; 80(5):669-70. PubMed ID: 9295009
[TBL] [Abstract][Full Text] [Related]
10. An advance in the treatment of portal hypertension?
Wong F; Blendis L
Gastroenterology; 2000 Apr; 118(4):802-3. PubMed ID: 10734033
[No Abstract] [Full Text] [Related]
11. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
DiNicolantonio JJ; Hackam DG
Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523
[TBL] [Abstract][Full Text] [Related]
12. [Therapy with beta blockers in heart failure. Recent studies of carvedilol].
Böhm M; Erdmann E
Fortschr Med; 1996 May; 114(13):167-8. PubMed ID: 8964561
[No Abstract] [Full Text] [Related]
13. Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker.
Wright DJ; Cooke GA; Tan LB
Heart; 1997 Jun; 77(6):581-2. PubMed ID: 9227309
[No Abstract] [Full Text] [Related]
14. Carvedilol [Coreg].
Kukin M
Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
[No Abstract] [Full Text] [Related]
15. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Lindenfeld J; Lowes BD; Bristow MR
Ann Pharmacother; 1999 Dec; 33(12):1266-9. PubMed ID: 10630826
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol outclasses the other beta-blockers.
Cardiovasc J S Afr; 2001; 12(2):120-1. PubMed ID: 11474696
[No Abstract] [Full Text] [Related]
17. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
[TBL] [Abstract][Full Text] [Related]
18. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients.
Moser M; Frishman W
Am J Hypertens; 1998 Jan; 11(1 Pt 2):15S-22S. PubMed ID: 9503102
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive profile of carvedilol.
Meyer-Sabellek W; Agrawal B
Clin Investig; 1992; 70 Suppl 1():S43-52. PubMed ID: 1350484
[TBL] [Abstract][Full Text] [Related]
20. Multiple action compounds in angina pectoris.
Kelly DT; Freedman SB
Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
